Molecular localization of LB-Q1, a DRw52-like T-cell recognition epitope and identification at the genomic level of associated shared hybridizing fragments.

[1]  M. Tilanus,et al.  An overview of the restriction fragment length polymorphism of the HLA-D region: its application to individual D-, DR- typing by computerized analyses. , 2008, Tissue antigens.

[2]  J. D. Capra,et al.  Biochemistry of MHC class II molecules. , 2008, Tissue antigens.

[3]  E. Thorsby,et al.  Identification of four SB antigens by cloned cells. Population studies of Norwegians. , 2008, Tissue antigens.

[4]  A. Termijtelen,et al.  The role of primary MLC of the non HLA-D/DR determinant PL3A. , 2008, Tissue antigens.

[5]  F. Bach,et al.  Clonal analysis of HLA-DR and -DQ associated determinants: their contribution to Dw specificities. , 1986, Human immunology.

[6]  B. Mach,et al.  Polymorphism of human Ia antigens: gene conversion between two DR β loci results in a new HLA-D/DR specificity , 1986, Nature.

[7]  D. K. Didier,et al.  Complete characterization and sequence of an HLA class II DR beta chain cDNA from the DR5 haplotype. , 1986, The Journal of biological chemistry.

[8]  B. Mach,et al.  Linkage map of three HLA-DR beta-chain genes: evidence for a recent duplication event. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Karr,et al.  Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies. , 1985, Journal of immunology.

[10]  C. Rabourdin-Combe,et al.  Serological and immunochemical analysis of the products of a single HLA DR-alpha and DR-beta chain gene expressed in a mouse cell line after DNA-mediated cotransformation reveals that the beta chain carries a known supertypic specificity , 1985, The Journal of experimental medicine.

[11]  T. Ottenhoff,et al.  HLA class II restriction repertoire of antigen-specific T cells. I. The main restriction determinants for antigen presentation are associated with HLA-D/DR and not with DP and DQ. , 1985, Human immunology.

[12]  E. Thorsby,et al.  Identification, at the genomic level, of an HLA-DR restriction element for cloned antigen-specific T4 cells , 1985, The Journal of experimental medicine.

[13]  T. Ottenhoff,et al.  HLA class II restriction repertoire of antigen-specific T cells. II. Evidence for a new restriction determinant associated with DRw52 and LB-Q1. , 1985, Human immunology.

[14]  J. Schiffenbauer,et al.  The molecules recognized by anti-MT2 alloantisera and anti-MT2-like (DRw52) monoclonal antibodies are different. , 1985, Human immunology.

[15]  K. Horibe,et al.  Biochemical and functional evidence that an MT3 supertypic determinant defined by a monoclonal antibody is carried on the DR molecule on HLA-DR7 cell lines. , 1984, Journal of immunology.

[16]  J. D. Capra,et al.  Molecular localization of human class II MT2 and MT3 determinants , 1984, The Journal of experimental medicine.

[17]  F. Koning,et al.  A mouse monoclonal antibody detecting a DR-related MT2-like specificity: serology and biochemistry. , 1984, Human immunology.

[18]  A. Termijtelen,et al.  LB-Q1 and LB-Q2: two determinants defined in the primed lymphocyte test and independent of HLA-D/DR, MB/LB-E, or SB. , 1983, Human immunology.

[19]  J. D. Capra,et al.  Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity , 1983, The Journal of experimental medicine.

[20]  J. Woody,et al.  SB-restricted presentation of influenza and herpes simplex virus antigens to human T-Iymphocyte clones , 1983, Nature.

[21]  J. Silver,et al.  Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR. , 1983, Journal of immunology.

[22]  Eric O Long,et al.  Isolation of distinct cDNA clones encoding HLA-DR beta chains by use of an expression assay. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Wernet,et al.  Differential inhibition of HLA-D- or SB-directed secondary lymphoproliferative responses with monoclonal antibodies detecting human Ia-like determinants. , 1982, Journal of immunology.

[24]  L. Nadler,et al.  Monoclonal antibodies defining serologically distinct HLA-D/DR related Ia-like antigens in man. , 1981, Human immunology.

[25]  P. Cresswell,et al.  HLA-A2 as a target for cell-mediated lympholysis: evidence from immunoselected HLA-A2 negative mutant cell lines. , 1980, Human immunology.

[26]  P Berg,et al.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. , 1977, Journal of molecular biology.

[27]  P Chambon,et al.  Isolation of high-molecular-weight DNA from mammalian cells. , 1973, European journal of biochemistry.

[28]  C. Scheffel,et al.  Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants , 2004, Immunogenetics.

[29]  E. Thorsby,et al.  T-Cell clones with similar antigen specificity may be restricted by DR, MT (DC), or SB class II HLA molecules , 2004, Immunogenetics.

[30]  R. Bontrop,et al.  Polymorphisms within the HLA-DR3 haplotypes , 2004, Immunogenetics.

[31]  C. Scheffel,et al.  Detection of HLA-DR associated PLT determinants by alloreactive lymphocyte clones , 2004, Immunogenetics.

[32]  P. Stastny,et al.  Recognition of class II molecules by human T cells , 2004, Immunogenetics.

[33]  B. Morolli,et al.  Dissection of HLA class II haplotypes in HLA-DR4 homozygous individuals , 2004, Immunogenetics.

[34]  R. Bontrop,et al.  Quantitative and qualitative differences in HLA‐DR molecules correlated with antigen‐presentation capacity , 1986, European journal of immunology.

[35]  M. Sánchez-Pérez,et al.  HLA-DP: Current Status , 1986 .

[36]  E. Thorsby The role of HLA in T cell activation. , 1984, Human immunology.

[37]  R. Demars,et al.  Analysis of DP Region Products by T Cells and Monoclonal Antibodies: Blocking of DP-Specific Proliferation and Cell-Mediated Cytotoxicity , 1984 .

[38]  C. Conighi,et al.  Antigen Report: HLA-DRw52 , 1984 .

[39]  J. Coligan,et al.  HLA‐DC antigens can serve as recognition elements for human cytotoxic T lymphocytes , 1984, European journal of immunology.

[40]  P. Stastny,et al.  Inhibition of antigen-specific T-cell lines by monoclonal antibodies , 1984 .

[41]  B. Malissen,et al.  Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal cell level of the cytolysis‐inhibiting effect of 7 monoclonal antibodies , 1982, European journal of immunology.

[42]  P. Wernet,et al.  Analysis of the HLA-linked SB gene system with cloned and uncloned alloreactive T-cell lines. , 1982, Immunogenetics.